Van Hulst Jack 4
4 · HI TECH PHARMACAL CO INC · Filed Oct 17, 2012
Insider Transaction Report
Form 4
Van Hulst Jack
Director
Transactions
- Sale
Common Stock
2012-10-16$32.75/sh−3,000$98,250→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2012-10-16−3,000→ 6,281 totalExercise: $5.83From: 2009-11-13Exp: 2018-11-13→ Common Stock (3,000 underlying) - Exercise/Conversion
Common Stock
2012-10-16$5.83/sh+3,000$17,490→ 3,000 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.70 to $32.80, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) of this Form 4.
- [F2]Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan.
- [F3]The option becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date.
- [F4]Other than the option reflected on this form, the filer is also the holder of additional options to acquire 30,000 shares of the Company's Common Stock (for total options to acquire an aggegate of 36,281 shares held by the filer), which options were granted on various dates with various exercise prices, exercisable dates and expiration dates.